Asali, Haneda A.
HRN: 27-22-15 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2025
CEFUROXIME 750MG (VIAL)
05/30/2025
06/05/2025
IV
750 Mg
Q8H
UTI
Checking Initial Appropriateness